Investigating Private Equity’s Stealthy Takeover of Health Care
As private equity extends into health care, evidence is mounting it’s led to higher prices and diminished quality of care, a KHN investigation has found.
Fred Schulte
Injuries Mount As Sales Reps For Device Makers Cozy Up To Surgeons
Aggressive sales tactics have allegedly led surgeons to use defective or wrong-size implants, screws or other products on patients.
Humana Health Plan Overcharged Medicare by Nearly $200 Million, Federal Audit Finds
The Health and Human Services Office of Inspector General's recommendation to repay, if finalized, would be “by far the largest” audit penalty ever imposed on a Medicare Advantage company.
Coronavirus Fuels Explosive Growth In Telehealth ― And Concern About Fraud
“There are unscrupulous providers out there, and they have much greater reach with telehealth,” said Mike Cohen, an operations officer with the Health and Human Services Inspector General’s Office.
Pandemic Delays Federal Probe Into Medicare Advantage Health Plans
Federal health officials, citing a need to focus on the COVID-19 pandemic, have temporarily halted some efforts to recover hundreds of millions of dollars in overpayments made to Medicare Advantage health plans.
Some States Are Reporting Incomplete COVID-19 Results, Blurring The Full Picture
Several states are reporting only positive COVID-19 test results from private labs, a practice that paints a misleading picture of how fast the disease is spreading.
New Federal Rules Will Let Patients Put Medical Records On Smartphones
Federal officials on Monday released groundbreaking rules that will let patients download their electronic health records and other health care data onto their smartphones.
Feds Want To Show Health Care Costs On Your Phone, But That Could Take Years
Federal officials are proposing new regulations that for the first time could allow patients to compare prices charged by various hospitals and other health care providers using data sent to their smartphones.
Rival Opioid Makers Sought To Cash In On Alarm Over OxyContin’s Dangers
When critics attacked Purdue Pharma for deaths linked to OxyContin, rivals stepped up their marketing of other potentially dangerous painkillers, such as fentanyl and morphine.
As Purdue Pharma faced mounting criticism over deaths linked to OxyContin, rival drugmakers saw a chance to boost sales by stepping up marketing of similarly dangerous painkillers, such as fentanyl, morphine and methadone, Purdue internal documents reveal.
How America Got Hooked On A Deadly Drug
Purdue Pharma left almost nothing to chance in its whirlwind marketing of its new painkiller OxyContin.
